# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T00:45:58.441185
**Response ID:** resp_0f79f06f5298aca50069794c728f2c8192a585b58d77799350
**Tokens:** 32728 in / 13206 out
**Response SHA256:** c4d3da2061e75500

---

Checked the draft strictly for **fatal** problems in the four categories you listed (data–design alignment, regression sanity, completeness, internal consistency). I do **not** see any issue that makes the empirical design impossible, the tables mechanically broken, or the manuscript incomplete in the “journal-wasting/embarrassing” sense.

### 1) DATA–DESIGN ALIGNMENT (critical)
- **Treatment timing vs data coverage:** Treatment cohorts (in-force years 2011, 2012, 2013, 2016, 2017) are all **≤ 2017**, and the key outcome is the **May 2017** referendum. Pre-period referendum outcomes (2000, 2003) and intermediate period (2016) are present as claimed.
- **Post-treatment observations:**  
  - Cross-sectional designs (OLS/RDD) use 2017 only → inherently post-treatment for treated cantons.  
  - Panel/DiD-style analysis has post-treatment observations for cohorts 2011/2012/2013/2016 in **2016 and 2017**; Basel-Stadt (2017 cohort) is explicitly excluded from Callaway–Sant’Anna because it has no usable post window beyond 2017. This is internally coherent.
- **Treatment definition consistency:** Treatment coding (in-force dates) is consistent across Table 1 / Table 9 and described as such.

**No fatal data–design mismatch found.**

### 2) REGRESSION SANITY (critical)
Scanned all reported regression-style tables for mechanical red flags:
- **Table 4 (OLS):** coefficients and SEs are in plausible ranges for % outcomes; Adj. R² values are within [0,1]; N reported.
- **Table 5 (RDD):** estimates/SEs/CI ranges are plausible and consistent with each other; bandwidths and side sample sizes are present.
- **Table 6 (balance tests), Table 8 (heterogeneity), Table 11/12/14/15:** no impossible values, no huge/absurd SEs, no NA/NaN/Inf, no R² violations (where applicable), no coefficient magnitudes that are mechanically impossible.

**No fatal regression-output pathology found.**

### 3) COMPLETENESS (critical)
- No obvious placeholders (“TBD”, “XXX”, NA/NaN/Inf cells) in the provided tables/figures.
- Regression tables include **N** and **SE/CI** as required.
- Methods described (OLS, spatial RDD, randomization inference, panel/event-study) have corresponding results shown (Tables 4–8, 11–15; Figures 6–14 etc.).

**No fatal incompleteness found.**

### 4) INTERNAL CONSISTENCY (critical)
Spot-checks of the key numeric claims against tables/figures:
- Raw treated–control gap in text (≈ −9.6 pp) matches **Table 3** and **Table 4 col (1)**.
- Language-region confounding magnitude matches **Table 4** language coefficients and the narrative.
- RDD headline estimate (−2.73, SE 1.10, p=0.014) matches **Table 5 spec (1)** and the corresponding figure caption.
- Randomization inference p≈0.62 matches **Figure 12** / **Table 15**.
- Treatment timing narrative matches **Table 9**.

**No fatal contradictions found.**

ADVISOR VERDICT: PASS